The TGF␤ superfamily comprises several bone morphogenetic proteins (BMP) capable of exerting gonadotropin-independent effects on the development of small preantral follicles. In embryonic tissues, BMP concentration gradients, partly formed by antagonistic factors, are essential for establishing phenotypic fate. By examining the expression of candidate genes whose protein products are known to interact with BMP ligands, we set out to determine which antagonists would most likely contribute toward regulation of paracrine signaling during early follicle development. Juvenile mouse ovaries of 4, 8, 12, and 21 d of age enriched with follicles at successive developmental stages were used to assess changes in candidate gene transcripts by quantitative RT-PCR. Although some antagonists were found to be positively associated with the emergence of developing follicles (Nog, Htra1, Fst, Bmper, Vwc2), two (Sostdc1, Chrd) showed a corresponding reduction in expression. At each age, twisted gastrulation homolog 1 (Twsg1), Htra1, Nbl1, and Fst were consistently highly expressed and localization of these genes by in situ hybridization, and immunohistochemistry further highlighted a clear pattern of expression in granulosa cells of developing follicles. Moreover, with the exception of Nbl1, levels of these antagonists did not change in preantral follicles exposed to FSH in vitro, suggesting regulation by local factors. The presence of multiple antagonists in the juvenile ovary and their high level of expression in follicles imply the actions of certain growth factors are subject to local modulation and further highlights another important level of intraovarian regulation of follicle development. 
The TGF␤ superfamily comprises several bone morphogenetic proteins (BMP) capable of exerting gonadotropin-independent effects on the development of small preantral follicles. In embryonic tissues, BMP concentration gradients, partly formed by antagonistic factors, are essential for establishing phenotypic fate. By examining the expression of candidate genes whose protein products are known to interact with BMP ligands, we set out to determine which antagonists would most likely contribute toward regulation of paracrine signaling during early follicle development. Juvenile mouse ovaries of 4, 8, 12 , and 21 d of age enriched with follicles at successive developmental stages were used to assess changes in candidate gene transcripts by quantitative RT-PCR. Although some antagonists were found to be positively associated with the emergence of developing follicles (Nog, Htra1, Fst, Bmper, Vwc2), two (Sostdc1, Chrd) showed a corresponding reduction in expression. At each age, twisted gastrulation homolog 1 (Twsg1), Htra1, Nbl1, and Fst were consistently highly expressed and localization of these genes by in situ hybridization, and immunohistochemistry further highlighted a clear pattern of expression in granulosa cells of developing follicles. Moreover, with the exception of Nbl1, levels of these antagonists did not change in preantral follicles exposed to FSH in vitro, suggesting regulation by local factors. The presence of multiple antagonists in the juvenile ovary and their high level of expression in follicles imply the actions of certain growth factors are subject to local modulation and further highlights another important level of intraovarian regulation of follicle development. I n the ovary, gonadotropin-independent early follicle development is regulated by inter-and intraovarian growth factors that mediate a dialog between different cell types (oocyte, granulosa, theca, stroma) and neighboring follicles (1) . Secreted factors known to contribute to these signaling networks include members of the TGF␤ superfamily, which consists of the growth differentiation factors (GDF), activins/inhibins, TGF␤ (TGF␤1, TGF␤2, TGF␤3), bone morphogenetic proteins (BMP), and others such as nodal and anti-Mü llerian hormone (AMH) (1, 2) . Although these members are closely related, most are expressed in the mammalian ovary in a distinct cell and follicle stage-specific pattern. For example, GDF9, BMP15, and BMP6 are almost exclusively restricted to growing oocytes (3) (4) (5) . AMH, inhibin, activin, BMP2, and BMP5 are detectable in granulosa cells (GC) of growing follicles (1, 6 -8) , whereas BMP4 and BMP7 are generally produced by thecal or stromal cells (7, 9) . Furthermore, receptors for these TGF␤ members including BMP receptor (BMPR)-1A, BMPR1B, and BMPR2 are expressed in all follicle cell types from an early stage [rat (7, 9) ; sheep (10) ]. Although it is not clear what regulates expression of TGF␤ receptors, several of the key ligands including BMP15, GDF9, TGF␤2, and inhibin are regulated in part by FSH (11) (12) (13) (14) .
Disruptions in the function or expression of key components of TGF␤ pathways have profound effects on the number and developmental potential of preantral follicles. For example, sheep and mice lacking functional BMP15 or GDF9, respectively, are sterile due to arrest in follicle development at the primary stage (15) (16) (17) . Compound mutant mice with GC-specific deletions of BMP pathway components such as BMPR1A and BMPR1B, or intracellular signaling SMAD proteins develop GC tumors (18, 19) . By comparison, mice with nonfunctional TGF␤ signaling SMAD in GC exhibit impaired follicle development and reduced ovulation efficiency (20) . Secretion of AMH by GC of developing follicles inhibits initiation of follicle growth in rodents (6) , whereas BMP7 has a stimulatory effect (21) . Other studies have demonstrated that the inhibition of endogenous BMP4 in mice through passive immunization caused a significant reduction in primordial follicle recruitment (22) . Furthermore, culture of neonatal rat ovaries in the presence of antibodies to BMP4 results in widespread apoptosis and follicle loss, whereas elevated BMP4 exposure increases the proportion of growing follicles (23) .
During development the level of exposure to specific growth factors regulates cell differentiation. For example, in Xenopus and Drosophila embryos, ectoderm cells require BMP signaling for their maintenance, but differentiation of these cells to become dorsal or ventral structures is mainly determined by the presence of extracellular BMP antagonists or binding proteins, which modify local concentrations of biologically active BMP (24, 25) . Antagonism of BMP in combination with their limited diffusion in the extracellular matrix allows for local concentration gradients to be established, which are essential for normal embryogenesis (24, 26) . Consequently, most loss-of-function mutants for the BMP antagonists are embryonic or perinatal lethal (27) ; hence, the role of these factors in normal adult physiology is not well defined.
Classical BMP antagonists share a unique cysteine knot structure, allowing them to specifically bind BMP (28) . Other factors lacking a cysteine knot structure have been identified that can similarly bind BMP and other TGF␤ ligands. Many BMP binding proteins antagonize signaling by physically preventing a receptor-ligand interaction (29) or by stabilizing the ligand, which can then be released in the presence of the appropriate enzyme (24, 25) . Little is known about the expression of BMP antagonists in the postnatal or adult ovary. Some exceptions include gremlin 1 and 2, which are up-regulated by FSH in GC of large preantral/antral follicles (30, 31) . Moreover, both of these factors, in addition to chordin and noggin, can neutralize BMP-regulated steroid production in follicle cells in vitro (30 -33) . In cumulus cells, expression of the BMP antagonists HtrA serine peptidase 1, noggin, and gremlin 2 are partly under the control of the oocyte (34) . Together these studies provide evidence for a functional role for these antagonists during later stages of follicle development.
It is evident that the intricate balance of TGF␤ members in time and space is necessary for follicles to develop (1, 9) . The generation of GC-specific compound mutants indicates that the ratio between TGF␤ and BMP signaling is a key mechanism (18 -20, 35) . Furthermore, the close juxtaposition of primordial and larger growing follicles in the ovary suggests that some spatially defined mechanism of regulation must operate. Careful analysis of the spatial distribution of resting and growing follicles in histological sections of juvenile mouse ovaries has provided mathematical evidence that primordial follicles produce a factor that inhibits the growth of neighboring primordial follicles (36) . Given the role of TGF␤ members, in particular BMP, in regulating early follicle development, the main objective of this study was to identify antagonists of the BMP that are expressed in the ovary and examine their relationship with the earliest stages of follicle development. We also examined the regulation of key antagonists by FSH in preantral follicles. Identifying the main components of intraovarian signaling networks will allow us to better understand how the initiation of follicle growth is regulated and how mammals maintain a sufficient supply of primordial follicles to last the reproductive life span, and provide enough growing follicles for regular ovulation.
Materials and Methods

Animals and tissue collection
Ovaries [4, 8, 12, 21, 42 d post partum (dpp)] and organs (42 dpp) were collected from C57BL/6 mice (day of birth 0 dpp) and either snap frozen in liquid nitrogen for quantitative RT-PCR or formalin fixed, paraffin embedded, and sectioned at 5 m for in situ hybridization (ISH) or immunohistochemistry. Oocytes and preantral follicles (14 dpp) and antral follicles (42 dpp) were mechanically isolated from ovaries and either processed for RNA isolation or cultured. Follicles were staged as described in Supplemental Materials and Methods, published on The Endocrine Society's Journals Online web site at http:// endo.endojournals. org. All mice were housed in accordance with the Animals (Scientific Procedures) Act of 1986 and associated Codes of Practice.
RT-PCR and quantitative PCR
Total RNA from organs was extracted with TriZol reagent according to the manufacturer's protocol (Invitrogen Ltd., Life Technologies, Paisley, UK), checked for integrity on agarose gels, and assessed for purity and concentration by spectroscopy (Nanodrop ND-1000; NanoDrop Technologies Inc., Wilmington, DE). RNA samples were adjusted to the same concentration and treated with deoxyribonuclease I (Invitrogen). For follicles and oocytes, RNA was isolated using RNeasy microcolumns (QIAGEN, Crawley, West Sussex, UK). cDNA was generated from all deoxyribonuclease-treated RNA samples using random hexamer primers and SuperScript II reverse transcriptase in accordance with the manufacturer's guidelines (Invitrogen). Primers were designed to detect mouse transcripts for the BMP antagonists listed in Supplemental Table 1 . Control primers included internal reference genes (Hprt1 and Atp5b; PrimerDesign Ltd., Southampton, UK) and positive control genes specific for the oocyte (Ddx4), GCs (Amh), and theca (Cyp17a1). A presence/absence screen for all BMP antagonists was performed using cDNA from a range of adult tissues and isolated follicles and oocytes using KAPA 2G Fast Hot Start Readymix (Labtech International, East Sussex, UK). For quantitative PCR, master mixes containing 500 nM primers were prepared with ABsolute QPCR SYBR Green Mix (Thermo Scientific, ABgene, Epsom, UK) and adjusted to 1ϫ concentration with nuclease-free water. The same amount of cDNA from each sample (equivalent to 10 ng of reverse transcribed RNA) was added to each reaction in duplicate alongside a dilution series of external standards and no-template (H 2 O) controls. Standards were prepared from cDNA identical to real-time PCR products and purified using QIAquick PCR purification columns (QIAGEN). The concentration of each purified standard was determined (Nanodrop) and diluted greater than 10 orders of magnitude in nuclease-free water. Amplification was monitored with the DNA Engine Opticon 2 (Bio-Rad Laboratories Ltd., Hemel Hemstead, Herts, UK) consisting of an initial activation step at 95 C for 15 min followed by 40 cycles of denaturation (95 C), primer-specific annealing, extension (72 C), and an amplicon-specific fluorescence acquisition reading (Supplemental Table 1 ). The identity of each gene product was confirmed by DNA sequence analysis (Geneservice Ltd., Cambridge, UK), and a melting curve analysis was performed for every sample to ensure consistent and specific amplification. For comparison of expression data, the cycle number at threshold (CT) of the samples was used to derive absolute values from the CT of the standards (femtograms per microgram reverse transcribed RNA). The linearity (r 2 ) of all standard curves was 0.995 or greater and the efficiency of amplification (E) based on E ϭ 10 Ϫslope Ϫ 1 was 0.92 or greater for all assays. For juvenile ovary and FSH-treated follicles, Hprt1 and Atp5b were deemed suitable internal reference genes, respectively, because their mean expression did not vary significantly between groups. Relative expression levels were calculated using the formula 2 -⌬⌬CT for both juvenile ovary and treated follicles. Absolute values and normalized fold changes within each group were analyzed by one-way ANOVA and where differences were detected (P Ͻ 0.05), post hoc Bonferroni multiple comparison tests were used; all results shown are mean Ϯ SEM for each group. The statistical analyses were performed using Prism 5 for Mac OS X (version 5.0b; GraphPad Inc., San Diego, CA).
Preparation of cRNA probes and in situ hybridization
Chemicals and reagents were purchased from Sigma (SigmaAldrich Company Ltd., Dorset, UK) except antidigoxigenin (DIG)-alkaline phosphatase (AP), 4-nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indoyl-phosphate, 4-toluidine salt solution and control labeled Neo RNA, which were purchased from Roche Diagnostics Ltd. (West Sussex, UK). Primers were designed and synthesized with a T7 RNA polymerase promoter sequence (TAATACGACTCACTATAGGGAGA) attached to the 5Ј end of the reverse primer and used to amplify regions of cDNA (Ͼ300 bp) specific to each gene of interest (Supplemental Table 2 ). All cRNA probes were transcribed from 500 ng to 1 g purified cDNA using the DIG RNA labeling kit (Roche) and were checked for labeling efficiency alongside dilutions of control labeled RNA (Roche) on a dot blot.
Details of the ISH procedure are given in the Supplemental Material. Briefly, sections of ovary were dewaxed, treated with proteinase K, and postfixed in 4% paraformaldehyde. Twentyfive microliters of probe were applied to each section, overlayed with a glass coverslip, and incubated overnight at 37 C in a humid chamber. Sections underwent a series of stringency washes, endogenous AP was quenched, and nonspecific binding blocked using 3% BSA in buffer AP1. After a 1-h exposure to anti-DIG-AP diluted 1:100 in blocking solution, sections were washed in buffer AP2 and developed in 4-nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indoyl-phosphate, 4-toluidine salt solution. Color reactions were monitored at room temperature and arrested in Tris-buffered saline after 4 -16 h and mounted with aqueous Faramount medium (Dako; Dako UK Ltd., Cambridgeshire, UK). Images were captured with a DS-Fi1 digital camera (Nikon UK Ltd., Kingston-upon-Thames, UK) attached to an E600 microscope (Nikon) using the NIS-Elements AR image analysis program (version 3.10; Nikon).
Immunohistochemistry
Sections were dewaxed and rehydrated. Antigen retrieval was performed by boiling slides in citrate buffer [10 mM citric acid (pH 6.0)] and nonspecific binding blocked using CAS-Block (30 min; Invitrogen). Primary antibodies used were rat anti-twisted gastrulation homolog 1 (TWSG1; 6.25 g/ml; R&D Systems Inc., Abingdon, UK), rabbit anti-htrA serine peptidase 1 (HTRA1; 6.25 g/ml; Abcam, Cambridge, UK), goat anti-neuroblastoma, suppressor of tumorigenicity 1 (NBL1; 2 g/ml; Santa Cruz Biotechnology Inc., Santa Cruz, CA), rabbit anti-SMAD1/5/8 (0.5 g/ml; Santa Cruz Biotechnology), phospho-SMAD1/5 (1:25; Cell Signaling Technology Inc., Danvers, MA) overnight at 4 C. After washes in PBS with 0.5% Tween 20, sections were incubated in the appropriate secondary antibody: antirat Alexa488, antirabbit Alexa555, or antigoat Alexa555 (1:200; all Invitrogen) for 60 min. Sections were mounted in Prolong Gold medium containing 4Ј,6Ј-diamino-2-phenylindole (DAPI, Invitrogen), and digital images were recorded using a Leica inverted SP5 confocal laser-scanning microscope (Leica Microsystems, Wetzlar, Germany).
Preantral follicle culture
Isolated follicles were cultured in MEM-␣ (Invitrogen) supplemented with 0.1% (wt/vol) BSA; 75 g/ml penicillin (Sigma); 100 g/ml streptomycin sulfate (Sigma); and a solution of insulin (5 g/ml), transferrin (5 g/ml), and sodium selenite (5 ng/ml; all Sigma) in 96-well plates. Single follicles were placed in individual wells containing 100 l medium supplemented with 0 (PBS vehicle), 1.0, or 10 ng/ml recombinant human (rh) FSH (National Hormone and Peptide Program, National Institute of Diabetes and Digestive and Kidney Diseases, Torrance, CA). At least six to eight follicles were cultured per treatment group for each plate, derived from an individual ovary. Cultures were maintained under humid conditions at 37 C with 5% CO 2 for up to 72 h, with 75% of the medium being replaced after 48 h. Follicles were photographed every 24 h, and measurements of the vertical and horizontal diameters were used to calculate the mean diameter and spherical volume for each follicle. Only follicles with a clearly identifiable, centrally placed round oocyte were included in the analysis. At 8, 24 , and 72 h, follicles were grouped by treatment and plate, immediately frozen in liquid nitrogen, and processed for RNA extraction, cDNA synthesis, and quantitative PCR as described above.
Results
Distribution of BMP antagonists in the adult mouse
Using RT-PCR, an initial presence/absence screen of adult tissues established the general tissue distribution of BMP antagonists in the mouse (Fig. 1) . Several antagonists were widely distributed across a range of tissues including Ctgf, Dand5, Htra1, Nbl1, and Twsg1, whereas others exhibited more variable tissue-specific expression such as Chrd, Fst, Grem1, Grem2, Sost, and Vwc2. Cerberus (Cer1) was undetectable by RT-PCR in any tissue under the current conditions but was weakly detectable when the cycle number was increased to 36 times (not shown). Of all 16 antagonists profiled, nine were consistently detectable in the adult ovary (Fig 1) .
Quantitative expression of BMP antagonists in the juvenile mouse ovary
Comparing transcript abundance in whole ovary (Fig.  2) , Twsg1, Htra1, Nbl1, and Fst were consistently the most highly expressed antagonists examined at each age. Bmper, Ctgf, Dand5, Fstl3, Grem2, and Vwc2 were expressed at a moderate level. By comparison, Chrd, Nog, Grem1, and Sostdc1 were generally expressed at a low level, whereas Cer1 and Sost were undetectable in the juvenile ovary.
When expression levels across the age groups were compared with that of d 4 levels in terms of fold change (Fig. 3) , a significant increase in expression was observed for Bmper, Htra1, Nog, and Vwc2, whereas Fst was elevated in d 21 relative to d 8 and 12. The increased expression of these factors therefore coincides with the emergence of larger follicles and/or associated structures (see Supplemental Fig. 1 ). Ctgf and Grem1 exhibited similar patterns of elevated expression with age (P ϭ 0.056 and P ϭ 0.03, respectively, ANOVA), but there was no significant difference in expression between specific days (post hoc test). By comparison, Dand5, Fstl3, Grem2, and Twsg1 were all consistently expressed throughout each of the age groups, suggesting either relatively constant follicular expression or expression from an extrafollicular compartment. Chrd and Sostdc1 were the only two factors that were significantly reduced in expression from d 4. Similarly, Nbl1 exhibited a trend toward a reduction in expression with increasing age (P ϭ 0.052, ANOVA).
Expression of BMP antagonists in isolated preantral follicles
To determine whether follicular BMP antagonist expression contributes toward overall ovarian expression, samples of oocytes and individual follicles from the transitional to large antral stage were collected and analyzed by RT-PCR (Fig. 4) . Consistent with overall low expression in whole ovaries, several factors including Cer1, Chrd, Sost, and Sostdc1 were undetectable in oocytes and preantral and antral follicles. Nog and Grem1 were barely detectable in antral follicle samples only. Bmper was absent in oocytes and was only weakly detectable in preantral follicles from the primary plus stage. Ctgf, Fst, Grem2, and Nbl1 mRNA was also absent in oocytes but detectable in all follicles from the transitional stage, suggesting GC as the main source of expression. Dand5 as well as follicles from the primary plus stage was weakly detectable in oocytes. Fstl3 was weakly detectable in oocytes and all follicle types examined. Htra1 and Twsg1 mRNA was detectable in all oocyte and follicle samples. By comparison, Vwc2 expression was weak in oocytes and secondary plus staged follicles only. 
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In situ localization of BMP antagonists in the juvenile ovary To further qualify transcript expression and to establish the precise location of selected BMP antagonists in the ovary, cRNA probes were prepared for four of the most abundantly expressed BMP antagonists including Twsg1, Htra1, Fst, and Nbl1 (Fig. 2) . Fst was also chosen as a control because the expression of this factor is well documented, and similarly, Gdf9 was included as an oocytespecific methodological control. In general, expression patterns demonstrated by ISH (Fig. 5) were found to closely resemble profiles of expression as determined by quantitative PCR (Fig. 3) ; factors that showed a significant increase in expression with age by quantitative PCR were easily detectable in large preantral and small antral follicle compartments found in d 21 ovaries by ISH, whereas those factors expressed at a more constant level across all age groups by quantitative PCR were detectable in follicles as well as other somatic cell compartments by ISH.
Expression of Twsg1 mRNA appeared to be almost ubiquitous in the ovary with a much stronger hybridization signal apparent in the GC of follicles of all stages of development including primordial (Fig. 5, A and B) . A strong signal was also detectable in theca cells of large antral follicles in the adult ovary as well as in the ovarian surface epithelium. A weaker hybridization signal was detectable in oocytes, stromal and interstitial cells, and some cells of the corpus luteum.
Htra1 antisense hybridization (Fig. 5 , C and D) was undetectable in primordial follicles but was weakly detectable in GC of follicles at the primary stage. From the primary stage, signal intensity remained relatively constant in GCs until the large preantral stage, whereafter signal strength increased considerably and became most intense in small antral sized follicles. In large antral follicles, Htra1 expression was almost absent from mural GC but remained in cumulus cells and those in close proximity to the antrum. Htra1 was also expressed in the corpus luteum.
Hybridization signal for Nbl1 (Fig. 5 , E and F) was apparent in most cell types in ovary at d 21, which was often difficult to discriminate from background levels due to the relatively low level of specific staining. Overall, signal strength appeared stronger in GC and ovarian surface epithelium relative to all other cell types. It was not possible to clearly identify Nbl1 expression in primordial and primary follicles; however, in the d 42 ovary, staining intensity was clearly strongest in the GC of large antral follicles. Staining was absent from corpora lutea.
For Fst antisense hybridization (Fig. 5, G and H) , a clear pattern of staining was observed in GC of developing follicles. No hybridization signal was detectable in primordial staged follicles, but a very weak signal could be observed in follicles at the primary stage. Hybridization intensity became stronger with increasing follicle size and was particularly strong in large preantral and small antral follicles. There was no evidence of Fst expression in any other ovarian cell type.
To confirm that the above hybridizations were not due to an unaccountable somatic cell artifact, a probe directed against Gdf9 mRNA was also hybridized to sections of ovary (Fig. 5, I and J). Gdf9 was expressed in oocytes of primary staged follicles and all subsequent stages. No specific staining was detectable in sections hybridized under similar conditions with a DIG-labeled bacterial control probe (Fig. 5, K and L) .
Immunohistochemical localization of ovarian BMP antagonists and intracellular SMAD
Sections of mouse ovary (21 dpp) were stained with antibodies against TWSG1, HTRA1, and NBL1 to relate protein expression with patterns of mRNA data and determine their compartmental relationship with the SMAD proteins (SMAD1/5/8) used for BMP signaling (Fig. 6) . TWSG1 was present in most cell types but appeared strongest in oocytes and GC of all follicle stages in a pattern similar to ISH. HTRA1 protein was also detectable in GC of follicles, the expression of which was particularly strong in follicles that had developed more than one layer of GC. NBL1 protein expression appeared ubiquitous in the ovary. By comparison, the nonphosphorylated form of SMAD1/5/8 was found in the GC compartment only. Unlike the antagonists, SMAD1/5/8 staining was absent in primordial follicles but was manifest from the transitional stage onward. Nuclear phospho-SMAD1/5 was generally found in GC of large preantral and small antral follicles, often in close proximity to the oocyte. GDF9, which was included as a control, was specific to oocytes of developing follicles (Fig. 6J) .
Regulation of BMP antagonists in preantral follicles by FSH
Because preantral follicles are known to respond to FSH and because Twsg1, Htra1, Nbl1, and Fst were all abundantly expressed in GC of the same stage follicles, we investigated the potential of FSH to regulate these factors in vitro (Fig. 7) . Expression of Gdf9, a marker of oocyte Upper and lower insets show an example of a primordial (arrow) and primary follicle, respectively. Examples of large preantral (Lp), small antral (Sa), large antral (La), and corpora lutea (CL) are also indicated. Gdf9 labeling was used as a positive procedural control because this gene is known to be oocyte specific. Control sections (Cntrl; K, L) were exposed to a DIGlabeled bacterial probe (Neo RNA; Roche) under the same hybridization conditions. For each gene, sections were also pretreated with ribonuclease before antisense probe hybridization and processed under the same conditions as above to assess any nonspecific staining from an RNA-independent source: no staining was detectable in any of these control sections (not shown). Scale bars on images, 100 m (3 wk), 250 m (6 wk), and 30 m (insets).
FIG. 6.
Immunolocalization of BMP antagonists and BMP signaling SMAD proteins in the immature mouse ovary. Sections of mouse ovary (21 dpp) were immunolabeled for TWSG1 (A), HTRA1 (C), and NBL1 (E), indicating expression of these antagonists in GC. SMAD1/5/8 (G) and phospho-SMAD1/5 (I) were also expressed in the GC compartment of developing follicles. GDF9 is shown as an oocyte-specific positive control (J). Corresponding species-specific Ig isotype controls (nonimmune IgG) applied to sections at an equivalent concentration as the primary antibody are shown for TWSG (B), HTRA1 (D), NBL1 (F), and SMAD1/5/8 (H). Nuclear counterstain is 4Ј,6Ј-diamino-2-phenylindole (blue). Scale bars, 100 m.
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viability, was unchanged after 24 h of culture in the absence of FSH (Fig. 7A) . To assess acute changes after FSH exposure, groups of follicles were assayed after 8 and 24 h in 10.0 ng/ml rhFSH. No differences were found for any genes assayed after 8 h (data not shown). A small but significant increase in Kitl1 was evident after 24 h. Conversely, a decrease in Nbl1 expression was found (P Ͻ 0.05), whereas Twsg1, Htra1 and Fst expression remained unchanged (Fig. 7C) . Preantral follicles cultured in the presence of either 1.0 or 10.0 ng/ml rhFSH grew at an increased rate compared with controls (0 ng/ml) so that after 48 h, follicles exposed to exogenous rhFSH were larger (P Ͻ 0.01) (Fig. 7B) . When follicles were collected at 72 h, kit ligand 1 (Kitl1), a factor known to be regulated by FSH was increased significantly in rhFSHtreated samples relative to controls confirming the bioactivity of rhFSH in this model (Fig. 7D ). In the same samples, Twsg1, Htra1, Nbl1, and Fst expression did not differ from control levels at either concentration of rhFSH (Fig. 7D) .
Discussion
Many studies have highlighted a role for intraovarian BMP as central mediators of follicle development (reviewed in Ref. 1). However, a major component of BMP regulation is via interaction with extracellular antagonists (27) . We therefore used the juvenile mouse ovary model to investigate changes in transcript levels for members of the BMP antagonist family during preantral follicle development. This study shows that a number of endogenous antagonists with known effects on BMP are expressed from a very early stage in follicle development (summarized in Table 1 ). We further investigated four factors that are highly expressed in the ovary: Twsg1, Htra1, Nbl1, and Fst. The presence of these antagonists in unilaminar follicles suggests regulation by intraovarian factors, and the lack of response to FSH indirectly supports this. An intriguing feature of these factors is their known ability to bind BMP2 and BMP4 as well as other TGF␤ members (37) (38) (39) (40) . We have also shown expression of other known BMP antagonists, some for the first time in ovary, identifying new potential regulatory factors. Of all antagonists examined, Twsg1 was one of the most abundantly expressed and its transcript was localized to GC and oocytes of follicles at all preantral stages including primordial. As an antagonist, TWSG1 can either bind directly with BMP2 and BMP4, or it can associate with both BMP/chordin to prevent receptor interaction by forming a more stable trimolecular complex (41, 42) . The latter state facilitates diffusion through the extracellular Individual follicles isolated from 14-dpp mice were cultured for up to 72 h in the presence or absence of FSH (six to eight follicles per group). In the absence of FSH, the expression of Gdf9, a marker of oocyte viability, was unchanged after 24 h in culture (A). Follicles exposed to 10.0 ng/ml FSH for 24 h had elevated expression of the FSH-responsive gene Kitl1 and a reduction in Nbl1 (P Ͻ 0.05) (B).
In long-term cultures, follicles exposed to either 10.0 ng ml FSH or a lower dose (1.0 ng/ml) were significantly larger than controls at 48 and 72 h (P Ͻ 0.01) (C space and therefore may contribute toward the formation of concentration gradients in developing tissues (43) . However, this is unlikely to operate in the ovary because chordin levels were low in whole ovary and almost undetectable in follicles. The lack of an effect of FSH on Twsg expression suggests that it is regulated by factors other than FSH. Together this highlights a locally regulated system involving TWSG1 that potentially binds and maintains the availability of BMP throughout follicle development. Htra1 was also highly expressed in GC from an early stage of follicle development, increasing to a maximal level in large preantral and small antral follicles. This concurs with previous studies that have also demonstrated that GC are a major source of Htra1 mRNA (44, 45) . Despite this expression pattern, Htra1 does not appear to be regulated by FSH in preantral follicles in our culture system or by pregnant mare serum gonadotropin administration in vivo (45) . HTRA1 is a unique serine protease that possesses the ability to cleave IGF binding proteins (46) and, in a screen of factors involved in ovulation, was implicated as a regulatory component of the ovarian extracellular matrix (45) . Like TWSG1, HTRA1 also has a high binding affinity to BMP4 and can inhibit BMP4 signaling both in vitro and in vivo (40) . Furthermore, HTRA1 has been shown to bind several other TGF␤ members including BMP2, TGF␤1, TGF␤2, activin, and GDF5 (40) .
Follistatin is well known for its role in antagonizing activin in the ovary and also for binding and inhibiting BMP2, BMP4, BMP5, BMP7, and BMP15 (33, 38, 47) .
Like Htra1, the pattern of Fst expression was mainly restricted to GC through the same stages of follicle development, consistent with previous studies (48 -50) . Follistatin expression in antral-derived GC in vitro can be regulated and augmented by factors such as TGF␤1, activin, and FSH (51) (52) (53) . The ability of FSH to induce follistatin expression may depend on follicle stage or be short lived [ϳ2 h in cultured rat GC; (53)], which may account for the lack of significant response observed in cultured preantral follicles. Fst and Htra1 mRNA were detectable in GC from the transitional/primary stage, and both were also relatively abundant in d 4 ovaries that are densely populated with primordial follicles. In fact, embryonic expression of follistatin is important for normal ovarian development (54) .
Consistent with our results, Nbl1 has previously been shown to be widely expressed in adult tissues. As with other highly expressed antagonists in the ovary, the physiological targets for NBL1 include GDF5 and BMP2 and BMP4 (37, 55) . However, little is known about the function of this gene in adult reproductive tissues. In the juvenile ovary, Nbl1 was expressed at relatively high levels, and its presence in most somatic cells implicates it as a potentially important regulator of local BMP. Despite this, null mutant mice have no obvious phenotypic abnormalities and are viable and fertile (37) . DAN domain family, member 5 is closely related to NBL1, and RT-PCR results indicate the transcript is also detectable in most tissues. The similar tissue distributions, albeit at different levels, and the lack of obvious phenotype in Nbl1 mutants, raises the possibility that some redundancy operates with these genes. In our screen of adult organs, gremlin 1 expression was strongest in the ovary relative to other tissues. However, we were unable to detect Grem1 at any appreciable level in juvenile ovaries until mice were 21 d old, suggesting that it may be either associated with larger follicles or is developmentally regulated. In support of the latter, a study by Pangas et al. (30) demonstrated that gremlin 1 expression is undetectable in small preantral follicles and can be induced by GDF9 and BMP4 in cultured GC derived from large antral follicles. Gremlin 1 is an important ovarian modulator of BMP4 signaling in large follicles (30, 32 ), yet it is not clear how this factor interacts with other BMP during early follicle development. On the other hand, gremlin 2, which shares a high degree of homology with gremlin 1, has been shown to be up-regulated in GC by FSH, and in vitro was found to inhibit the downstream luciferase reporter activity of BMP2 and BMP4 and to a lesser extent BMP6 and BMP7 (31). The same authors were able to detect the Grem2 transcript from the small antral stage by ISH. Using RT-PCR on isolated follicles, we were able to detect Grem2 from the earlier transitional stage, perhaps reflecting the difference in sensitivity of the two techniques. Collectively these studies indicate that both gremlin 1 and gremlin 2 are important regulators of BMP in the ovary, although the more abundant expression of Grem2 in the juvenile ovary suggests they may have distinct but overlapping roles at different stages of follicle development.
Connective-tissue growth factor (CTGF) is another factor well documented in the ovary and known to be regulated by FSH in GC (56) . CTGF is growth factor with a wide range of functions in many different tissues that can also bind and inhibit the actions of BMP4 and enhance the actions of TGF␤1 (57). We found Ctgf mRNA was first expressed in transitional/primary stage follicles with abundant expression in preantral follicles. This agrees with other studies in rat, which have also shown that Ctgf can be induced by GDF9, activin, and TGF␤1 in nondifferentiated GC (56, 58) .
In this study we have shown moderate expression of the antagonist Bmper in ovary. BMP binding endothelial regulator (BMPER) can bind BMP ligands, including BMP4, and has a very strong affinity for chordin. In other model systems, this affinity between BMPER and chordin is believed to be sufficiently strong enough to establish morphogenetic fields by the attraction and relocation of chordin complexes (43) , but our finding of low levels of Chrd in ovary does not support this mode of action. The expression and role of BMPER has yet to be determined in ovarian physiology.
Historically noggin was one of the first BMP antagonists to be characterized due to its ability to influence patterning during embryogenesis (59) . In various cultured cell lines, noggin protein reportedly binds BMP2, BMP4, BMP5, BMP6, and BMP7 as well as GDF5 and GDF6, and this ability to bind a broad range of ligands means it is often used as a tool to experimentally block BMP activity (27) . In sheep GC, noggin has been shown to neutralize the effect of BMP2 and BMP4 on reducing progesterone production in vitro, although noggin was undetectable in sheep ovary (33) , supporting our findings of low expression of this antagonist in juvenile mouse ovaries. Similarly, chordin was able to neutralize the ability of BMP4 and BMP7 to suppress androgen production in bovine theca cells (32) . Our finding that noggin and chordin are absent in mouse follicles suggests that although they are effective inhibitors of BMP, they may not have a biological role in ovarian physiology. Similarly, the lack of expression of Sostdc1, Cer1, and Sost in adult ovary, together with the fertility and viability of null mutants for Sostdc1 and Cer1 (60, 61) , suggests that these antagonists play little or no role in the regulation of follicle development in the mouse. However, they may still be important factors in other species. For instance, there is a case report of a woman with a mutation in the Nog gene who suffered premature ovarian failure (62) , and splice variants of Chrd with biological activity have been reported for the adult human ovary (63) . Moreover, because many of the BMP antagonists can be regulated by the ligand they antagonize (64) , this raises the possibility that variation in antagonist expression between species may reflect the reported variation in expression of BMP in different species (65) .
Based on their expression patterns, this study highlights antagonists that are most likely involved in regulating BMP members in the ovary, particularly during the early stages of follicle development. Factors such as Twsg1, Htra1, and Fst predominate in GC from an early stage, and a common feature of these antagonists is their known affinity for BMP4. This may be physiologically relevant in ovary because evidence from previous studies supports a role for this BMP in the initiation and survival of primordial follicles (22, 23) . Considerable progress has been made in understanding the role of TGF␤ members in mammalian follicle development by studying animals that either have mutations in, or lack specific ligands, receptors, or downstream signaling molecules (35) . The presence of antagonists highlighted in this study provides a framework for addressing a further extracellular level of regulation of BMP signaling that may be essential for normal follicle development.
